Listed lender BNP Paribas has granted a Sustainability-Linked Loan (SLL) to listed pharmaceutical group Neuca in the form of a current account facility of PLN 50 million (EUR 11.7 mln) and a factoring facility of PLN 100 million (EUR 23.4 mln), the bank announced in a press release.
Bank BNP Paribas udzielił kredytu w formule Sustainability-Linked Loan (SLL) Grupie Neuca w rachunku bieżącym w wysokości 50 mln zł oraz limitu faktoringowego w kwocie 100 mln zł - podał bank w komunikacie prasowym.
Listed pharmaceutical company Neuca expects an improvement in the profitability of the entire clinical trials segment in 2026. It anticipates the completion of an acquisition in the SMO sector in a new market, company representatives announced. Despite lower-than-expected growth in the wholesale pharmaceutical distribution market in the first quarter, it is not revising its forecast for the whole of 2026.
Neuca oczekuje w 2026 r. poprawy rentowności całego segmentu badań klinicznych. Spodziewa się zamknięcia akwizycji w obszarze SMO na nowym rynku - poinformowali przedstawiciele spółki. Mimo niższej od oczekiwań dynamiki wzrostu rynku hurtowej dystrybucji leków w I kw. nie rewiduje prognozy na cały 2026 r.
Listed pharmaceutical company Neuca posted an EBITDA of PLN 88.1 million (EUR 20.6 mln) and attributable net profit of PLN 27.1 million (EUR 6.3 mln) in the fourth quarter of 2025, the company said in its finanacial report. While the EBITDA result was in line with PAP Biznes consensus, the net take turned out to be 16 pct lower than expectations.
Listed pharmaceutical company Neuca's management board recommends paying a dividend of PLN 17.8 (EUR 4.17) per share from its 2025 profit, the company announced in its annual financial report.
